ICE原糖期货反弹，但周线百分比跌幅有望接近两位数

Crispr Therapeutics AG ADR（CRSP）跌超10%，此前，美国食品药品管理局（FDA）批准该公司参与开发的基因疗法，该疗法Casgevy用于治疗镰形红细胞（sickle cell），媒体称，每个病患的医疗成本大约200万美元。","multimedia":{"img_url":["https://n.sinaimg.cn/zhibo/280/w1080h2400/20231209/9985-b59acb2330b63c8638090e7b3e0c17e4.jpg"]},"commentid":"live:finance-152-3401749:0","compere_id":0,"creator":"litong7@staff.sina.com.cn","mender":"litong7@staff.sina.com.cn","create_time":"2023-12-09 00:51:25","update_time":"2023-12-09 00:52:25","is_need_check":"0","check_time":"1970-01-01 08:00:01","check_status":"1","check_user":"","is_delete":0,"top_value":0,"is_focus":0,"source_content_id":"0","anchor_image_url":"","anchor":"直播员","ext":"{"stocks":[{"market":"us","symbol":"crsp","key":"CRISPR Therapeutics AG"},{"market":"fund","symbol":"159891","key":"医疗"}],"needPush":false,"needAIPush":false,"needCMSLink":true,"needCalender":false,"needProvince":"0"}","old_live_cid":"0","tab":"","is_repeat":"0","tag":[{"id":"3","name":"公司"},{"id":"5","name":"市场"}],"like_nums":0,"comment_list":{"list":[],"total":0,"thread_show":0,"qreply":0,"qreply_show":0,"show":0},"docurl":"","rich_text_nick_to_url":[],"rich_text_nick_to_routeUri":[],"compere_info":""},{"id":3401748,"zhibo_id":152,"type":0,"rich_text":"【ICE原糖期货反弹，但周线百分比跌幅有望接近两位数】洲际交易所（ICE）原糖期货周五上涨，不过按百分比跌幅来看，周线仍有望录得近两位数的跌幅，市场因头号生产国巴西供应增加而承压。交易商表示，鉴于印度仍不允许出口，印度指示糖厂专注于糖产量，而不是使用甘蔗汁或糖浆生产乙醇的举措，并不像人们想象的那样悲观。交易商指出，基金继续轧平多头仓位或直接做空，这意味着近期糖价可能继续下滑。